Skip to main content

Advertisement

SpringerLink
Log in

Therapy related acute myeloid leukemia after exposure to 5-Fluorouracil: a case report

  • Original articles
  • Published:
Hematology and Cell Therapy

Abstract

Therapy related acute myeloid leukemia occurs after exposure to various cytotoxic agents. Among typical chemotherapeutic agents are the alkylating agents and topoisomarese II inhibitors. This type of leukemia has been reported after the use of antimetabolites. We report here a patient who developed therapy related acute myeloid leukemia secondary to the use of 5-fluorouracil.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Institute of Oncology, Department of Basic Oncology, Hacettepe University, 06100, Sthhiye, Ankara, Turkey

    A. Turker

  2. Institute of Oncology, Department of Medical Oncology, Hacettepe University, 06100, Sthhiye, Ankara, Turkey

    N. Güler

Authors
  1. A. Turker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Güler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turker, A., Güler, N. Therapy related acute myeloid leukemia after exposure to 5-Fluorouracil: a case report. Hematol Cell Ther 41, 195–196 (1999). https://doi.org/10.1007/s00282-999-0195-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00282-999-0195-3

Key words

Search

Navigation